【レポートの概要（一部）】
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, By Indication
5.1 Introduction
5.2 Breast Cancer
5.3 Colorectal Cancer
5.4 Lung Cancer
5.5 Others Indications
6 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, By Blocking Drug
6.1 Introduction
6.2 Monoclonal Antibodies
6.2.1 Cetuximab
6.2.2 Necitumumab
6.3 Tyrosine Kinase Inhibitors (TKI)
6.3.1 Erlotinib
6.3.2 Gefitinib
7 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Amgen Inc
9.2 Bristol-Myers Squibb
9.3 Erbitux
9.4 F. Hoffmann-La Roche Ltd
9.5 Genentech, Inc
9.6 OSI Pharmaceuticals Inc
9.7 Tarceva
9.8 Vectibix
List of Tables
Table 1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 6 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 7 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 8 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 9 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 10 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 11 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 12 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 13 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 14 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 15 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 16 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 17 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 18 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 19 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 20 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 21 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 22 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 23 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 24 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 25 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 26 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 27 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 28 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 29 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 30 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 31 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 32 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 33 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 34 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 35 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 36 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 37 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 38 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 39 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 40 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 41 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 42 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 43 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 44 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 45 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 46 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 47 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 48 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 49 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 50 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 51 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 52 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 53 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 54 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 55 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 56 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 57 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 58 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 59 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 60 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 61 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 62 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 63 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 64 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 65 South America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
Table 66 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Country (2016-2026) ($MN)
Table 67 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Indication (2016-2026) ($MN)
Table 68 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Breast Cancer (2016-2026) ($MN)
Table 69 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Colorectal Cancer (2016-2026) ($MN)
Table 70 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Lung Cancer (2016-2026) ($MN)
Table 71 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Others Indications (2016-2026) ($MN)
Table 72 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Blocking Drug (2016-2026) ($MN)
Table 73 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Monoclonal Antibodies (2016-2026) ($MN)
Table 74 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Cetuximab (2016-2026) ($MN)
Table 75 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Necitumumab (2016-2026) ($MN)
Table 76 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Tyrosine Kinase Inhibitors (TKI) (2016-2026) ($MN)
Table 77 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Erlotinib (2016-2026) ($MN)
Table 78 Middle East & Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Outlook, By Gefitinib (2016-2026) ($MN)
【レポート販売概要】
■ タイトル：上皮増殖因子受容体（EGFR）阻害薬の世界市場展望2017-2026■ 英文：Epidermal Growth Factor Receptor (EGFR) Inhibitors - Global Market Outlook (2017-2026)
■ 発行日：2019年6月
■ 調査会社：Stratistics MRC
■ 商品コード：SMRC90773
■ 調査対象地域：グローバル
- 炭素繊維強化プラスチック（CFRP）複合材料の世界市場The consumption of carbon fibre reinforced composites has increased significantly in recent years and is expected to grow at a more rapid pace during the coming decade. The CFRP composites market has been dominated by North America, accounting for over a third of the global market. However, we expect the European and Asian regions to expand more rapidly, where growth rates perform above the global …
- カラー化粧品の世界市場2015-2019Technavio market research analyst predicts the global color cosmetics market to grow at a CAGR of around 5% during the forecast period. The rising consciousness about appearance among the younger population is driving the growth of the market globally. The engagement is high among women between the age of 25 to 34, who are interested in the benefits of the product and prefer long-lasting products …
- スベリン酸の世界市場2015Suberic Acid (CAS 505-48-6) Market Research Report 2015 aims at providing comprehensive data on Suberic Acid market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Suberic Acid description, covers its application areas, manufacturing methods, patterns. It captures Suberic Acid market trends, pays close attention to Suberic Acid manufacturers and names …
- 心臓モニタリング及び診断装置（医療機器）のグローバル市場（2012-2018）The Cardiac Monitoring and Diagnostic Devices market is expected to reach US$2.3 billion by 2017 primarily supported by the segments: types - Telemetry Systems, ECG Devices and Holter Monitor. Globally, Event Monitors and ECG Devices together account for approximately 33% of the market are expected to support the Cardiovascular Devices industry going forward. Geographical analysis shows that the h …
- 世界の電子パッケージ市場動向（2014-2018）TechNavio’s analysts forecast the Global Electronic Packaging market will grow at a CAGR of 46.79 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing thefts and counterfeiting practices. The Global Electronic Packaging market has also been witnessing a rising number of innovations. However, lack of awareness about the potential of electron …
- 世界の子宮内膜症（Endometriosis）市場動向（2012-2016）TechNavio's analysts forecast the Global Endometriosis market to grow at a CAGR of 5.86 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased number of incidence rates of endometriosis. The market has also been witnessing an increased number of awareness programs. However, poor safety and efficacy of existing drugs could pose a challenge to t …
- ビジネスインテリジェンス（BI）の世界市場予測（～2021年）“Increasing adoption of cloud is driving the growth”MarketsandMarkets expects the global Business Intelligence (BI) market to grow from USD 17.09 billion in 2016 to USD 26.88 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 9.5%. The BI market is growing rapidly because of the transition from traditional techniques to advanced BI and analytics techniques, and the massive adoption of clo …
- 企業エンドポイント・サイバーセキュリティの世界市場2015-2020This new report offers comprehensive analysis of enterprise endpoint cyber security solutions and related companies. Visiongain assesses that the enterprise endpoint cyber security market will reach $4.98bn in 2015. Visiongain’s report will ensure that you keep informed and ahead of your competitors. Gain that competitive advantage. The report will answer questions such as: • How is the Enterprise …
- 医薬品有効成分（API）の世界市場規模及び予測：合成別（バイオ技術、合成）、メーカー種類別（キャプティブ、マーチャント）、種類別（一般、革新的）、用途別、動向分析 2014-2025The global active pharmaceutical pngredients (API) market is expected to reach a value of USD 239.8 billion by 2025, based on a new report by Grand View Research, Inc. The rising prevalence of lifestyle-induced & age-related diseases and cancer is projected to drive the market over the forecast period. Advancements in recombinant molecular technologies and high capitalization for development of no …
- プリプレグの世界市場：炭素繊維プリプレグ、ガラス繊維プリプレグ、アラミド繊維プリプレグThe market size of prepreg is projected to reach USD 8.64 Billion by 2021, growing at a CAGR of 10.12%, between 2016 and 2021. The increasing demand for lightweight and high performance materials in the wind energy, aerospace & defense, automotive, and sporting goods applications are the key factors driving the growth of the prepreg market. The global prepreg market is segmented into fiber reinfor …
- DRaaS（クラウド式災害復旧サービス）の世界市場：バックアップ、リアルタイム複製、データセキュリティ、プロフェッショナルサービスMarketsandMarkets forecasts the Disaster Recovery as a Service (DRaaS) market size to grow from USD 1.68 Billion in 2016 to USD 11.11 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 45.9% from 2016 to 2021. Faster data recovery, cost-effectiveness, greater flexibility, automation capabilities, and simple testing features of DR services are the key factors driving the growth of the Disa …
- 肺炎ワクチンの世界市場：ワクチン種類別（肺炎球菌複合ワクチン、肺炎球菌多糖ワクチン）、製品種類別（Prevnar 13、Synflorix、Pneumovax 23）、セクター別（公共、民間）、流通チャンネル別（流通パートナー企業、非政府組織・政府当局）The global pneumonia vaccines market was valued at $7,083 million in 2017 and is expected to reach $10,215 million by 2025, growing at a CAGR of 5% from 2018 to 2025. Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Pneumonia results in inflammation in the air sacs (kn …
- 電子顕微鏡の世界市場（～2025）The Electron Microscopes Market in 2014 generated over $2 billion globally in revenues. Main players in the market are Hitachi, Carl Zeiss, FEI and Jeol. Market drivers for advanced microscopy include the increase in the complexity and performance level of devices used in electronic products, reduction of manufacturing costs, increased resolution, increasing device complexity and shrinking geometr …
- ファサードの世界市場分析：製品別（換気、換気なし、カーテンウォール）、エンドユーザー別（商業用、住居用、産業用）、材料別（アルミ、プラスチック･繊維、ガラス）、セグメント予測The global facades market size is expected to reach USD 339.46 billion by 2024, according to a new study by Grand View Research, Inc. The surge inthe adoption of advanced eco-friendly facades across North America and Europe is anticipated to fuel the market growth in the coming years. Furthermore, the increasing number of new building constructions, along with the rise in the number of renovation …
- 鉱業用運炭装置の世界市場2019-2023About this market Coal mining has traditionally been a labor-intensive industry. However, the growing competitiveness in the renewable energy sector and the emergence of substitutes for coal have accelerated the adoption of automation in coal mining to make mining productive and efficient. Furthermore, the share of coal extracted using the underground coal mining method continues to increase in th …
